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Abstract
Rationale: Although there have been several studies describing clinical and radiographic features about the novel coronavirus
(COVID-19) infection, there is a lack of pathologic data conducted on biopsies or autopsies.
Patientconcerns:A 56-year-old and a 70-year-old men with fever, cough, and respiratory fatigue were admitted to the intensive
care unit and intubated for respiratory distress.
Diagnosis: The nasopharyngeal swab was positive for COVID-19 and the chest Computed Tomography (CT) scan showed the
presence of peripheral and bilateral ground-glass opacities.
Interventions:Both patients developed pneumothoraces after intubation and was managed with chest tube. Due to persistent air
leak, thoracoscopies with blebs resection and pleurectomies were performed on 23rd and 16th days from symptoms onset.
Outcomes: The procedures were successful with no evidence of postoperative air-leak, with respiratory improvement.
Pathological specimens were analyzed with evidence of diffuse alveolar septum disruption, interstitium thickness, and infiltration of
inflammatory cells with diffuse endothelial dysfunction and hemorrhagic thrombosis.
Lessons:Despite well-known pulmonary damages induced by the COVID-19, the late-phase histological changes include diffused
peripheral vessels endothelial hyperplasia, in toto muscular wall thickening, and intravascular hemorrhagic thrombosis.
Abbreviations: COVID-19 = novel coronavirus 2019, CRP = C-reactive protein, CT = Computed Tomography, ICU = Intensive
Care Unit, PEEP = positive end-expiratory pressure, WBC = white blood cells.
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1. Introduction
The outbreak of the novel coronavirus (COVID-19) infection
was first reported inWuhan, China. The subsequent spread of the
disease led to the worldwide diffusion since the World Health
Organization declared the pandemic state. Although there have
been several studies describing the clinical and radiographic
features about the COVID-19 infection,[1,2] there is a lack of
pathologic informations conducted on biopsies or autopsies.[3–5]
A previous study reported data of 2 asymptomatic patients
treated for lung adenocarcinoma and retrospectively diagnosed
with COVID-19.[3] The described pathological features were
accidental and likely to be early in asymptomatic patients.
Therefore, the histological findings associated with advanced
phase of the disease remain unclear.With this report we described
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the late stage histological findings of 2 symptomatic COVID-19
patients intubated for respiratory insufficiency.
2. Case presentation
Written informed consent was obtained from the patients
relatives for publication of the case details and accompanying
images.
2.1. Case #1
A 56-year old man, active smoker, was admitted to our hospital
with fever, cough, and respiratory distress. Admission laboratory
exams were: WBC: 18.200/mm3; neutrophils: 54%; CRP: 21.3
mg/dl, D-dimer: 15.442mg/L. The nasopharyngeal swab was
positive for COVID-19 and the chest Computed Tomography
(CT) scan showed presence of peripheral and bilateral ground-
glass opacities (Fig. 1A). He was admitted to the Intensive Care
Unit (ICU) and later intubated for respiratory insufficiency.
Ventilator settings were: tidal volume 6ml/kg and PEEP 10
cmH2O. The patient developed post-intubation pneumothorax
and was managed with a 28 Fr chest tube. Due to persistent air
leak, thoracoscopy (Fig. 2) with blebs resection and pleurectomy
was performed on day 23rd after symptoms onset.[6]
2.2. Cases #2
A 70-year old man without comorbidities was admitted to our
hospital with fever, fatigue, and respiratory distress. Laboratory
exams were: WBC: 14.700/mm3; neutrophils: 48%; CRP: 16.1
mg/dl, D-dimer: 12.891mg/L. Diagnosis of COVID-19 was done
with positive nasopharyngeal swab and evidence of bilateral
ground-glass opacities was shown on thorax CT scan (Fig. 1B).
He was admitted to the ICU and intubated for respiratory
insufficiency. Ventilator settings were: tidal volume 6ml/kg and
PEEP 8cmH2O. He also developed pneumothorax required the
positioning of a 28 Fr chest tube. Again, because of persistent air
leak, thoracoscopy with blebs resection and pleurectomy was
performed on 16th day from symptoms onset.[6]
During the hospital course, both patients received vitamin C,
hydroxychloroquine, and azithromycin. The surgical procedures
were successful in both patients with no evidence of persistent air-
leak and respiratory improvement. Drains were removed in both
patients on postoperative day 2. Despite the initial respiratory
improvement patient#1 passed away 56 days after symptoms
Figure 2. The thoracoscopic evaluation showed a stiff, edematous, and congestive lung parenchyma with superficial blebs.
Figure 1. A-B. Chest Computed Tomography scan showing bilateral ground
glass opacities with multilobar involvement.
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onset because of cardiac failure. Patient #2 was estubated and
discharged from the ICU 28 days after symptoms onset.
Specimens were analyzed and pathological findings showed no
evidence of pathognomonic lesions. The gross tissue evaluation
showed diffuse congestive appearance with edema and haemor-
rhagic necrosis. The main pathological changes consisted is
alveolar damage with septa disruption, desquamation, edema,
and proteinaceous exudates (Fig. 3). Alveolar congestion was
prominent and contained edema fluid, desquamated epithelial
and inflammatory cells. The interstitial tissue was mildly fibrotic
and thickened with cells infiltration (monocytes, lymphocytes,
plasma cells, and multinucleate giant cells) (Fig. 4). Immunohis-
tochemistry showed positive results for TTF-1, NapsineA, CD3,
CD34, CD5, CD8, CD31, CK7, and Collagen Type IV.
Peripheral vessels showed diffused endothelial hyperplasia, in
toto muscular wall thickening, and massive intravascular
hemorrhagic thrombosis (Fig. 5).
3. Discussion
The novel coronavirus 2019 (COVID-19), also known as severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an
enveloped, non-segmented positive-sense RNA virus causing
severe bilateral pneumonia and acute respiratory distress
syndrome (ARDS) in patients. The most commonly reported
symptoms are fever, cough, myalgia, and dyspnea.[7] Up to 15%
of patients may develop severe symptoms and respiratory fatigue
requiring mechanical ventilation and intensive care unit
management.[8] Diagnosis is made with a nasopharyngeal swab,
Figure 3. Representative hematoxylin and eosin section of the lung (15X) - Massive alveoli damage with hemorrhagic necrosis end interstitial fibrosis.
Figure 4. Representative hematoxylin and eosin section of the lung (45X) - alveolar damage with desquamate epithelial cells and inflammatory cells infiltration.
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immunoglobulin serum tests, and evidence of bilateral and
multiple patchy or ground glass appearance at chest CT scan.
Although clinical and radiographic findings in COVID-19
patients have been largely reported, there is a lack of pathologic
informations conducted on biopsies or autopsies and the
literature is scarce. The early histologic changes of 2 patients
that underwent lung lobectomy for adenocarcinoma and
retrospectively diagnosed with COVID-19 have been previously
described.[3] Edema, proteinaceous exudate, focal reactive
hyperplasia of pneumocytes with inflammatory cellular infiltra-
tion were prominent in the pathological specimens. To our
knowledge, this report by Tian and colleagues represents the first
description of pulmonary changes induced by COVID-19.[3]
However, the described tissue alterations were the early-phase
changes in asymptomatic subjects andmay not be totally accurate
for symptomatic patients. Therefore, our study managed to
broaden Tian and colleagues report by describing the pathologi-
cal changes of 2 symptomatic COVID-19 patients intubated for
respiratory distress. Bronchiolitis and alveolitis with prolifera-
tion, atrophy, and desquamation of alveolar epithelial cells were
present confirming the direct tropism of the virus for alveolar
cells. This is in accordance with a recently published series
describing postmortem findings of firm and severely congested
lung parenchyma with concomitant exudative diffuse alveolar
damage.[9] The selective tropism of the COVID-19 for the
angiotensin converting enzyme 2 (ACE2), exposed in type II
alveolar cells, results in cells damage and apoptosis with
consequent acute alveoli injury, septum disruption, and pulmo-
nary edema. The interstitial tissue is thickened due to sustained
fibroblast activation with a significant amount of infiltrated
inflammatory cells triggered via the circulating pro-inflammatory
“cytokine storm” (i.e. TNF, IL-1b, IL-6, etc.).[10] The thickened
interstitium correspond to the characteristic radiographic find-
ings of peripheral ground-glass opacity detected by chest
computed tomography. Diffuse peripheral vessels involvement,
endothelial thickening, and diffuse intraluminal hemorrhagic
thrombosis, consistent with a generalized microvascular injury
was found in both cases. ACE2 receptors are expressed by
endothelial cells and recent findings showed direct evidence of
viral elements within endothelial cytoplasm.[11] It is likely that the
direct viral and complement-mediated endothelial injury cause a
widespread alteration of the endothelial homeostasis with
consequent microvascular dysfunction and shift of the vascular
equilibrium towards a procoagulant state.[12] This further
support the recently described findings of capillarostasis, vascular
congestion, alveolar capillaries microthrombi, and pulmonary
embolism.[13,14] These features may correlate with the late phase
of disease-induced coagulopathy and consequent increase of lung
dead space, presumably cause of respiratory distress necessitating
mechanical support.
4. Conclusion
To our knowledge, this is the first report describing the late phase
histological findings of 2 symptomatic COVID-19 patients
intubated for respiratory distress. Despite the well-known
pulmonary damage, the late-phase tissue alterations include
diffused peripheral vessels endothelial hyperplasia, in toto
muscular wall thickening, and intravascular hemorrhagic
thrombosis. These findings may provide new insights into the
specific COVID-19 pneumonia pathogenesis, which might be
useful for focused and timely therapeutic strategies.
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Figure 5. Representative hematoxylin and eosin section of the lung (45X) – Intravascular hemorrhagic thrombosis, with in toto muscular wall thickening and
endothelial hyperplasia.
Aiolfi et al. Medicine (2020) 99:28 Medicine
4
References
[1] Zhu N, Zhang D,WangW, et al. A novel coronavirus from patients with
pneumonia in China, 2019. N Engl J Med 2020;doi.org/10.1056/
NEJMoa2001017.
[2] Chung M, Bernheim A, Mei X, et al. CT imaging features of 2019 novel
coronavirus (2019-nCoV). Radiology 2020;295:202–7.
[3] Tian S, Hu W, Niu L, et al. Pulmonary pathology of early-phase 2019
novel coronavirus (COVID-19) pneumonia in two patients with lung
cancer. J Thorac Oncol 2020;pii: S1556-0864(20)30132-5. doi:
10.1016/j.jtho.2020.02.010. [Epub ahead of print].
[4] Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19
associated with acute respiratory distress syndrome. Lancet Respir Med
2020;8:420–2. Epub 2020 Feb 18.
[5] LuoW, YuH, Gou , et al. Clinical pathology of critical patient with novel
coronavirus pneumonia (COVID-19). Preprints 2020;2020020407.
[6] Aiolfi A, Biraghi T, Montisci A, et al. Management of persistent
pneumothorax with thoracoscopy and blebs resection in covid-19
patients. Ann Thorac Surg 2020;pii: S0003-4975(20)30604-4.
[7] Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of
COVID-19 patients in northeast Chongqing. J Med Virol 2020;1–0.
doi:10.1002/jmv.25783.
[8] Wang Wang D, Hu B, Hu C, et al. Clinical characteristics of
138 hospitalized patients with 2019 novel coronavirus-infected
pneumonia in Wuhan, China. JAMA 2020;doi.org/10.1001/jama.
2020.1585.
[9] Menter T, Haslbauer JD, Nienhold R, et al. Post-mortem xxamination of
COVID19 patients reveals diffuse alveolar damage with severe capillary
congestion and variegated findings of lungs and other organs suggesting
vascular dysfunction. Histopathology 2020;doi: 10.1111/his.14134.
Online ahead of print.
[10] Mehta P, McAuley DF, Brown M, et al. HLH across speciality
collaboration, UK. COVID-19: consider cytokine storm syndromes and
immunosuppression. Lancet 2020;395:1033–4. Epub 2020 Mar 16.
[11] Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and
endotheliitis in COVID-19. Lancet 2020;pii: S0140-6736(20)30937-5.
doi: 10.1016/S0140-6736(20)30937-5. [Epub ahead of print].
[12] Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic
or thromboembolic disease: implications for prevention, antithrombotic
therapy, and follow-up. J Am Coll Cardiol 2020;[PMID: 32311448]
doi:10.1016/j.jacc.2020.04.031.
[13] Wichmann D, Sperhake JP, LütgehetmannM, et al. Autopsy findings and
venous thromboembolism in patients with COVID-19. Ann Intern Med
2020;M20–2003. doi: 10.7326/M20-2003.
[14] Lax SF, Skok K, Zechner P, et al. Pulmonary arterial thrombosis in
COVID-19 with fatal outcome: results from a prospective, single-center,
clinicopathologic case series. Ann Intern Med 2020;doi: 10.7326/M20-
2566. Online ahead of print.
Aiolfi et al. Medicine (2020) 99:28 www.md-journal.com
5
